Who owns ABVC BIOPHARMA INC?
- Ticker: ABVC
- CUSIP Number: 00091f304
Tip: Access positions for across all investors
Analyze quarterly positions in Abvc Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Abvc Biopharma stock
Who bought or sold ABVC BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 288k | $613k | 8% | Dec 2025 |
|
| Geode Capital Management | 221k | $215k | 9% | Mar 2026 |
|
| Vanguard Capital Management | 191k | $185k | 100% | Mar 2026 |
|
| Renaissance Technologies | 114k | $243k | 3% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 97k | $94k | 100% | Mar 2026 |
|
| State Street Corporation | 73k | $155k | 0% | Dec 2025 |
|
| BlackRock | 56k | $55k | 0% | Mar 2026 |
|
| Northern Trust | 32k | $68k | 29% | Dec 2025 |
|
| Two Sigma Securities | 21k | $20k | 100% | Mar 2026 |
|
| Susquehanna International | 20k | $43k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 12k | $12k | 100% | Mar 2026 |
|
| XTX Topco | 11k | $24k | -55% | Dec 2025 |
|
| Jane Street | 11k | $10k | -2% | Mar 2026 |
|
| Squarepoint Ops | 11k | $10k | 100% | Mar 2026 |
|
| Tower Research Capital | 3.2k | $6.8k | 48% | Dec 2025 |
|
| UBS Group | 1.8k | $1.7k | -32% | Mar 2026 |
|
| Simplex Trading | 196.00 | $417.009600 | -82% | Dec 2025 |
|
| Royal Bank of Canada | 17.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Abvc Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 56k | $118k |
| Morgan Stanley | Dec 2025 | 5.2k | $10k |